Skip to content

Drug interactions

Eluxadoline + Paclitaxel

Severity: Moderate

Eluxadoline and Paclitaxel: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Paclitaxel may inhibit OATP1B1 and raise eluxadoline exposure, which may increase adverse effects such as constipation, nausea and pancreatitis. Eluxadoline is also associated with sphincter of Oddi spasm.

What this interaction means in plain words

Eluxadoline and Paclitaxel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eluxadoline belongs to Gastrointestinal Tract; Paclitaxel belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of OATP1B1-mediated hepatic uptake of eluxadoline.

What to do

Reduce eluxadoline to 75 mg twice daily if given with OATP1B1 inhibitors, and monitor for abdominal pain, constipation and pancreatitis symptoms.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eluxadoline and Paclitaxel, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eluxadoline with Paclitaxel?

MediHelp rates the interaction as moderate. Eluxadoline and Paclitaxel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Paclitaxel may inhibit OATP1B1 and raise eluxadoline exposure, which may increase adverse effects such as constipation, nausea and pancreatitis. Eluxadoline is also associated with sphincter of Oddi spasm.

How serious is the interaction between Eluxadoline and Paclitaxel?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce eluxadoline to 75 mg twice daily if given with OATP1B1 inhibitors, and monitor for abdominal pain, constipation and pancreatitis symptoms.

What other medicines interact with Paclitaxel?

MediHelp also lists interactions of Paclitaxel with, for example, Adenovirus types 4 and 7 live, Cobicistat, Cyclosporine. The full list is on the Paclitaxel page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in